Elizabeth Kudlacz
Department of Immunology
Pfizer Global Research and Development
Groton
Connecticut 06340
USA
Name/email consistency: high
- The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models. Kudlacz, E., Perry, B., Sawyer, P., Conklyn, M., McCurdy, S., Brissette, W., Flanagan And, M., Changelian, P. Am. J. Transplant. (2004)
- Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule alpha4beta1 antagonists. Kudlacz, E., Whitney, C., Andresen, C., Duplantier, A., Beckius, G., Chupak, L., Klein, A., Kraus, K., Milici, A. J. Pharmacol. Exp. Ther. (2002)
- Functional effects of eotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils. Kudlacz, E., Whitney, C., Andresenl, C., Conklyn, M. Inflammation (2002)
- Genetic ablation of the src kinase p59fynT exacerbates pulmonary inflammation in an allergic mouse model. Kudlacz, E.M., Andresen, C.J., Salafia, M., Whitney, C.A., Naclerio, B., Changelian, P.S. Am. J. Respir. Cell Mol. Biol. (2001)